These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 21519356)
1. Heart rate: a forgotten link in coronary artery disease? Fox KM; Ferrari R Nat Rev Cardiol; 2011 Apr; 8(7):369-79. PubMed ID: 21519356 [TBL] [Abstract][Full Text] [Related]
3. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction. Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917 [TBL] [Abstract][Full Text] [Related]
4. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction. Rosano GM; Vitale C; Volterrani M Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895 [TBL] [Abstract][Full Text] [Related]
5. Ivabradine: the hope for a good treatment of ischemic heart disease. Riccioni G Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554 [TBL] [Abstract][Full Text] [Related]
6. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy. Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS Cardiovasc Hematol Agents Med Chem; 2015; 13(1):4-9. PubMed ID: 25544120 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction. Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043 [TBL] [Abstract][Full Text] [Related]
14. Ivabradine in stable coronary artery disease without clinical heart failure. Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R; N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136 [TBL] [Abstract][Full Text] [Related]
15. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Fox K; Ford I; Steg PG; Tendera M; Ferrari R; Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088 [TBL] [Abstract][Full Text] [Related]
16. Clinical perspectives of heart rate slowing for coronary event reduction and heart failure. Danchin N; Kadri Z Adv Cardiol; 2006; 43():45-53. PubMed ID: 16936471 [TBL] [Abstract][Full Text] [Related]
17. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. DiFrancesco D; Camm JA Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560 [TBL] [Abstract][Full Text] [Related]
20. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease. Ferrari R; Ceconi C Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]